U.S. Infrastructure Stock News

NYSE:VMI
NYSE:VMIConstruction

How Investors Are Reacting To Valmont Industries (VMI) Russell Index Exit And New 2029 Targets

In late June 2026, Valmont Industries, Inc. was removed from the Russell 1000 Value-Defensive and Russell 1000 Defensive Indexes, shortly after issuing 2029 guidance targeting a 17% operating margin and US$35 earnings per share and releasing its 2026 Sustainability Report. This combination of index exclusion, long-term financial targets, and reinforced sustainability positioning raises fresh questions about how different investor groups may view Valmont’s risk profile and long-range value...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

SLM (SLM) Following Russell Index Removal Still Looks Undervalued On Its Growth Story

SLM (SLM) has been removed from several Russell growth benchmarks, including the Russell 1000, 2500, 3000 and related growth indices. This shift can meaningfully influence index fund ownership and trading volumes. See our latest analysis for SLM. Despite being dropped from several Russell growth indices, SLM's recent trading has been resilient, with a 7 day share price return of 14.32% and a 90 day share price return of 21.95%. This is set against a 1 year total shareholder return that is...
NasdaqGS:FRSH
NasdaqGS:FRSHSoftware

Freshworks (FRSH) Joins Russell Indexes, Is The Stock Still Undervalued?

Why Freshworks’ Index Additions Matter for Shareholders Freshworks (FRSH) was recently added to several Russell indices, including the Russell 2000 and Russell 3000 value and defensive benchmarks. This change can draw more attention from index-tracking investors. These inclusions often put a stock on the radar of funds that mirror or reference these indices, which can influence trading volumes and liquidity. For existing and prospective shareholders, the change creates a fresh context for...
NYSE:HRI
NYSE:HRITrade Distributors

Herc Holdings (HRI) Joins Russell Value Indexes Following A Fair Value Question

Herc Holdings (HRI) has been added to several Russell value benchmarks, including the Russell 3000E Value, 3000 Value, 2000 Value, 2500 Value and Russell Small Cap Comp Value indexes, drawing fresh attention from index-tracking investors. See our latest analysis for Herc Holdings. Those index additions come after a sharp run in Herc Holdings' share price, with a 90 day share price return of 46.95% and 30 day share price return of 9.99%, even though the year to date share price return is down...
NYSE:LVS
NYSE:LVSHospitality

Is Macau Margin Pressure Ahead of Q2 Earnings Altering The Investment Case For Las Vegas Sands (LVS)?

Earlier this month, Las Vegas Sands reported better-than-expected first-quarter 2026 adjusted earnings and revenue, but investors focused on weaker Macau margins amid intense competition and rising promotional costs as the company prepared to release its second-quarter results. The tension between solid top-line performance and pressure on profitability in Macau highlights how sensitive the business is to even small changes in promotional spending and competitive intensity. We’ll now examine...
NYSE:GPOR
NYSE:GPOROil and Gas

Does Gulfport’s Shift Into Russell Value and Small‑Cap Indices Recast the Bull Case For GPOR?

In late June 2026, Gulfport Energy Corporation (NYSE: GPOR) was added to multiple Russell value and small-cap indices, including the Russell 2000 Value-Defensive and Russell 3000 Value benchmarks, while being removed from the Russell 2000 Dynamic Index. This broad inclusion across value-oriented and small-cap benchmarks may reshape Gulfport’s investor base as index-tracking and factor-focused funds adjust their portfolios. Next, we’ll examine how Gulfport’s broad addition to Russell value...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Is Rezolve AI (RZLV) Undervalued Following Its $300 Million Buyback And 2026 Guidance?

Rezolve AI (RZLV) is back on investors’ radar after unveiling a $300 million share repurchase plan, reaffirming its 2026 revenue guidance around $360 million and expanding its Reward platform into Mashreq’s Visa Card Linked Offers program. See our latest analysis for Rezolve AI. The recent buyback announcement and Mashreq partnership come after a mixed year for Rezolve AI’s stock, with the share price up 1.56% over 90 days but down 12.75% over 30 days, and the 1 year total shareholder return...
NYSE:MMI
NYSE:MMIReal Estate

Marcus & Millichap (MMI) Gains Attention, Is The Stock Now Pricey?

Why Marcus & Millichap Stock Is on Investors’ Radar Marcus & Millichap (MMI) has drawn fresh attention after recent trading left the stock with a roughly 10% gain over the past month and about 17% over the past 3 months. See our latest analysis for Marcus & Millichap. Against a latest share price of $31.21, Marcus & Millichap’s 7 day share price return of 8.33% and 90 day share price return of 17.38% contrast with a 1 year total shareholder return of 3.41% and 5 year total shareholder return...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

XP (XP) Following Russell Index Removal Still Looks Undervalued On The Popular View

Index removal puts XP in focus XP (NasdaqGS:XP) has been removed from several Russell growth benchmarks, a shift that typically prompts index fund rebalancing and can influence short term demand for the stock among passive investors. See our latest analysis for XP. XP's share price has been choppy, with a 1 day share price return of 1.12% and a 90 day share price return that is down 14.34%, while the 1 year total shareholder return has also declined 17.39%. This points to fading momentum...
NYSE:HAWK
NYSE:HAWKAerospace & Defense

Rocket Lab News Has Investors Rethinking Aerospace And Satellite Communication Stocks

SpaceX’s rebound and fresh enthusiasm around satellite communications have turned a niche corner of aerospace into a focus for many investors overnight. With call option activity heavily outweighing puts and Rocket Lab’s new agreement with Iridium Communications drawing attention to space related partnerships, interest is spreading beyond private markets and smaller contractors. This article looks at how that news connects back to large, financially solid aerospace stocks, and identifies 3...
NasdaqCM:LXRX
NasdaqCM:LXRXPharmaceuticals

Lexicon Pharmaceuticals (LXRX) Joins Russell Indexes, Is The Stock Still A Bargain?

Index additions put Lexicon Pharmaceuticals in focus Lexicon Pharmaceuticals (LXRX) has just been added to multiple Russell indexes and growth benchmarks, a move that can influence trading activity as index tracking funds adjust their portfolios. This wave of index inclusions places Lexicon Pharmaceuticals on the radar of a broader set of institutional and retail investors. For you, the key question is how this new exposure interacts with the company’s fundamentals and recent share price...
NasdaqGS:PCAR
NasdaqGS:PCARMachinery

PACCAR (PCAR) Tests Its Growth Narrative After Recent Moves As Value Stays In Focus

PACCAR (PCAR) is in focus after recent share price moves, with the stock last closing at $119.60 and showing mixed short term performance, including a small decline over the past day and past week. See our latest analysis for PACCAR. Recent moves in PACCAR’s share price sit within a broader upward trend, with an 8.36% 1 month share price return and a 29% 1 year total shareholder return indicating momentum that investors are reassessing against the current valuation. If you are comparing...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Is Intel (INTC) Expensive After AI And Foundry Momentum Fueled Its Rerating?

Intel (INTC) has been at the center of renewed investor attention after a series of AI focused partnerships, foundry customer wins, leadership changes, and upbeat commentary from several major Wall Street firms. See our latest analysis for Intel. Intel’s recent AI partnerships, foundry customer wins, and index inclusion line up with powerful share price momentum, with a 30 day share price return of 14.86% and a 1 year total shareholder return of 476.46%. Together, these figures point to...
NasdaqGS:KALU
NasdaqGS:KALUMetals and Mining

How Kaiser’s Shift Into Russell 2000 Defensive Indices Will Impact Kaiser Aluminum (KALU) Investors

In late June 2026, Kaiser Aluminum Corporation was removed from several Russell value-focused benchmarks but added to the Russell 2000 Defensive and Russell 2000 Growth-Defensive indices, reflecting a shift in how it is classified within the broader market. This reshuffling of index memberships can meaningfully influence trading flows and the composition of institutional holders, as passive funds tracking these benchmarks adjust their positions. We’ll now examine how Kaiser Aluminum’s move...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Is Protagonist Therapeutics (PTGX) A Bargain As Its Pipeline Momentum Lifts The Stock?

Protagonist Therapeutics (PTGX) stock has attracted fresh attention recently, supported by strong trailing total returns and new interest in its clinical pipeline. This has prompted investors to reassess how current pricing lines up with underlying fundamentals. See our latest analysis for Protagonist Therapeutics. At a share price of $121.63, Protagonist Therapeutics has shown strong momentum, with a 30 day share price return of 22.17% and a year to date share price return of 39.52%. Longer...
NasdaqGS:LFST
NasdaqGS:LFSTHealthcare

Is LifeStance Health Group (LFST) Overvalued Following Its Russell Index Removals?

Index removals put LifeStance Health Group in focus for investors LifeStance Health Group (LFST) has been removed from several Russell indexes, including the Russell 2000, 2500, 3000, and related value and defensive benchmarks. This change can reshape how some institutional investors treat the stock. See our latest analysis for LifeStance Health Group. Despite being dropped from several Russell indexes, LifeStance Health Group’s recent trading has been strong, with a 30 day share price return...
NYSE:PNC
NYSE:PNCBanks

PNC Financial Services Group (PNC) Following Its 18% Dividend Hike Looks Modestly Undervalued

PNC Financial Services Group (PNC) is back in focus after management recommended an 18% increase in the quarterly cash dividend to $2.00 per share, subject to board approval in July 2026. See our latest analysis for PNC Financial Services Group. Recent price action has been strong for PNC Financial Services Group, with the share price at $246.73 after an 11.58% 1 month share price return and 18.57% 3 month share price return. That move sits alongside a 36.80% 1 year total shareholder return...
NYSE:BFLY
NYSE:BFLYMedical Equipment

Tesla Stock And 2 High Growth Tech Names With Strong Insider Ownership

Global markets are being pulled in different directions by shifting rate expectations, mixed growth signals, and changing energy prices, which leaves many investors looking for companies where management’s interests are closely aligned with their own. Fast growing stocks with high insider ownership can offer that alignment, as leaders who hold meaningful stakes are often highly focused on long term value creation. This article highlights why that theme stands out in the current macro...
NYSE:DOCS
NYSE:DOCSHealthcare Services

Doximity (DOCS) Faces A BofA Downgrade, Is The AI Growth Story Still Undervalued?

Downgrade and Index Shifts Put Doximity Back Under the Microscope Doximity (DOCS) is back in focus after BofA Securities cut its rating and revenue outlook, citing uncertainty around the company’s AI driven growth plans and potential pressure on margins from higher investment spending. See our latest analysis for Doximity. At a share price of $20.59, Doximity has seen short term share price momentum soften. The 30 day share price return is down 3.79% and the year to date share price return is...
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Is Payoneer Global (PAYO) Fully Valued Following Its Russell 2000 Index Inclusion?

Payoneer Global (PAYO) was recently added to both the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index, an inclusion that can influence index-tracking fund flows, trading activity, and overall investor attention. See our latest analysis for Payoneer Global. That index inclusion comes after a period of strong momentum for Payoneer Global, with the share price delivering a 30-day return of 36.35% and a 90-day return of 46.79%. The 3-year total shareholder return stands...
NasdaqGS:BOKF
NasdaqGS:BOKFBanks

Is BOK Financial (BOKF) Below Fair Value After Its Russell 1000 Index Removal?

BOK Financial (BOKF) has been removed from the Russell 1000 Dynamic Index. This index adjustment can influence trading flows as passive and rules based investors rebalance their holdings. See our latest analysis for BOK Financial. At a share price of $138.52, BOK Financial has a 1-month share price return of 8.18% and a year-to-date share price return of 16.72%. Its 1-year total shareholder return of 44.87% and 3-year total shareholder return of 80.56% point to solid longer term gains,...
NYSE:VAL
NYSE:VALEnergy Services

Valaris (VAL) Is Down 6.7% After Russell Growth Reclassification Shifted Its Index Profile – Has The Bull Case Changed?

In late June 2026, Valaris Limited (NYSE: VAL) was added to several Russell growth benchmarks, including the Russell 2000, 2500, 3000, 3000E and Small Cap Composite Growth Indexes, while being removed from the Russell 2000 Defensive and Russell 2000 Value-Defensive Indexes. This reclassification signals a meaningful shift in how index providers and, by extension, many institutional investors categorize Valaris, potentially altering who holds the stock and how it is used in portfolios. We’ll...
NasdaqGS:BCPC
NasdaqGS:BCPCChemicals

How Balchem’s Broad Russell Value Index Additions Will Impact Balchem (BCPC) Investors

Balchem Corporation (NasdaqGS: BCPC) was recently added to multiple Russell value and small-cap indexes, including the Russell 2000 Value-Defensive Index, Russell 3000 Value Benchmark, Russell 3000E Value Benchmark, Russell Small Cap Comp Value Benchmark, Russell 2500 Value Benchmark, and Russell 2000 Value Benchmark. This broad index inclusion can increase Balchem’s visibility with institutional investors and passive funds, potentially reshaping how the market views its role in...
NasdaqCM:AVTX
NasdaqCM:AVTXBiotechs

Why Avalo Therapeutics (AVTX) Is Up 12.9% After Broad Russell Index Inclusion And Pipeline Progress

Avalo Therapeutics recently joined a wide range of Russell indices, including the Russell 3000, Russell 2000, Russell 2500, and related growth, value, small-cap, and micro-cap benchmarks, broadening its visibility across the U.S. equity landscape. This sweeping index inclusion, alongside the appointment of veteran biopharma executive Ron Philip to the board and advancement of AVTX-010, highlights Avalo’s increasing presence in both capital markets and inflammatory disease drug...